Prenatal Genetic Testing for Beckwith‐Wiedemann Syndrome: Considerations, Challenges and Observations (A Real‐World Study)
Prenatal Diagnosis · 2026-08 · 46 (9) · 1486-1493
DOI: 10.1002/pd.70206 ↗At a glance
Journal article in Prenatal Diagnosis, published online on 2026-06-25. Written by Melissa Connolly and 10 co-authors. Institution: West Midlands Genomics Laboratory, Birmingham, UK. Major MEDLINE topics: Beckwith-Wiedemann Syndrome, Genetic Testing, Prenatal Diagnosis. 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft, Italian Ministery of Healt.
Abstract (original language)
Objective
Prenatal genetic testing for imprinting disorders is rarely requested with the exception of Beckwith‐Wiedemann syndrome (BWS) which is associated with specific ultrasound findings (e.g., placental mesenchymal dysplasia, omphalocele). However, genetic testing for BWS is challenging as aberrant DNA methylation has to be addressed which often occur as mosaicism. As a growing number of requests for prenatal BWS testing is observed, data from genetic prenatal BWS testing was compiled to delineate its suitability as well as limitations.
Method
Three European laboratories compiled the experiences from 646 prenatal samples. The samples were analysed by methylation‐specific assays targeting the imprinting centres in 11p15.5, in a sub‐cohort CDKN1C was sequenced.
Results
The overall detection rate for BWS specific molecular disturbances was 9.75%, and the spectrum of alterations reflected that from postnatal BWS cohorts. The rate of failing samples was in total 4.3%, nearly all failures were observed in native samples.
Conclusion
Prenatal testing for BWS should be considered in pregnancies with ultrasound findings or family history suggestive for BWS. In the majority of tests, evaluable results can be achieved, though mosaicism can never be excluded and therefore false‐negative results are possible.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- West Midlands Genomics Laboratory, Birmingham, UK.
- Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto 2 Auxologico Italiano, Milan, Italy.
- MVZ Genetikum GmbH, Center for Human Genetics, Neu-Ulm, Germany.
- Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
- MVZ Genetikum GmbH, Center for Human Genetics, Stuttgart, Germany.
- Center for Human Genetics and Genome Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
ORCID profiles: Matthias Begemann, Katja Eggermann, Thomas Eggermann, Silvia Russo
Funding
- Deutsche Forschungsgemeinschaft
- Italian Ministery of Healt
Cite
APA
Connolly, M., McClelland, L., Tannorella, P., Richter, T., Mainini, E., Dufke, A., Lischka, A., Begemann, M., Eggermann, K., Eggermann, T., & Russo, S. (2026). Prenatal Genetic Testing for Beckwith‐Wiedemann Syndrome: Considerations, Challenges and Observations (A Real‐World Study). Prenatal Diagnosis, 46(9), 1486-1493. https://doi.org/10.1002/pd.70206
Vancouver
Connolly M, McClelland L, Tannorella P, Richter T, Mainini E, Dufke A, et al. Prenatal Genetic Testing for Beckwith‐Wiedemann Syndrome: Considerations, Challenges and Observations (A Real‐World Study). Prenatal Diagnosis. 2026;46(9):1486-1493. doi:10.1002/pd.70206
BibTeX
@article{Connolly2026,
author = {Connolly, Melissa and McClelland, Louise and Tannorella, Pierpaola and Richter, Tanja and Mainini, Ester and Dufke, Andreas and Lischka, Annette and Begemann, Matthias and Eggermann, Katja and Eggermann, Thomas and Russo, Silvia},
title = {Prenatal Genetic Testing for Beckwith‐Wiedemann Syndrome: Considerations, Challenges and Observations (A Real‐World Study)},
journal = {Prenatal Diagnosis},
year = {2026},
volume = {46},
number = {9},
pages = {1486--1493},
doi = {10.1002/pd.70206}
}
EUVIMED